Cumberland Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7M | Sell |
46,570
-177
| -0.4% | -$78.8K | 1.44% | 22 |
|
|
2025
Q1 | $22.7M | Sell |
46,747
-579
| -1% | -$281K | 1.75% | 20 |
|
|
2024
Q4 | $19.1M | Buy |
47,326
+4,126
| +10% | +$1.66M | 1.33% | 22 |
|
|
2024
Q3 | $20.1M | Buy |
43,200
+14,541
| +51% | +$6.76M | 1.39% | 23 |
|
|
2024
Q2 | $13.4M | Sell |
28,659
-728
| -2% | -$341K | 0.98% | 27 |
|
|
2024
Q1 | $12.3M | Buy |
+29,387
| New | +$12.3M | 0.89% | 30 |
|
|
2021
Q1 | – | Sell |
-115
| Closed | -$27K | – | 197 |
|
|
2020
Q4 | $27K | Buy |
+115
| New | +$27K | ﹤0.01% | 165 |
|